These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 4384191
41. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Rzeszutek M, Wierzbowski A, Hoban DJ, Conly J, Bishai W, Zhanel GG. Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306 [Abstract] [Full Text] [Related]
42. [Resistant pneumococci]. Garau J, Liñares J. Med Clin (Barc); 1985 May 04; 84(17):688-90. PubMed ID: 4010372 [No Abstract] [Full Text] [Related]
43. [Antibiotic-resistant pneumococci. 2 case report]. Hebert JP, Caillet R. Nouv Presse Med; 1980 Mar 29; 9(15):1098-9. PubMed ID: 7465382 [No Abstract] [Full Text] [Related]
44. [Rondomycin in the treatment of pneumonia in infants]. Gerkowicz T, Karska M, Lewicka-Urbańska B. Pol Tyg Lek; 1969 May 05; 24(18):688-9. PubMed ID: 5801934 [No Abstract] [Full Text] [Related]
45. Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group. Cetron MS, Jernigan DB, Breiman RF. Emerg Infect Dis; 1995 May 05; 1(2):64-5. PubMed ID: 8903164 [No Abstract] [Full Text] [Related]
46. Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints. Brueggemann AB, Doern GV. Am J Manag Care; 2000 Dec 05; 6(23 Suppl):S1189-96. PubMed ID: 11187442 [Abstract] [Full Text] [Related]
47. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Yao KH, Wang LB, Zhao GM, Zheng YJ, Deng L, Huang JF, Wang JX, Zhao RZ, Deng QL, Hu YH, Yu SJ, Yang YH, Young M. Vaccine; 2011 Mar 09; 29(12):2296-301. PubMed ID: 21276441 [Abstract] [Full Text] [Related]
48. [Severe resistant pneumococcal infection in a child]. Mersch JM, Furioli J, Fremaux A, Berardi-Grassias LD. Arch Fr Pediatr; 1990 May 09; 47(5):397-8. PubMed ID: 2369277 [No Abstract] [Full Text] [Related]
49. Some aspects of the pneumococcal carrier state. Austrian R. J Antimicrob Chemother; 1986 Jul 09; 18 Suppl A():35-45. PubMed ID: 3745031 [No Abstract] [Full Text] [Related]
50. Serotypes, antimicrobial resistance and genotypes of Streptococcus pneumoniae associated with infections in cancer patients in Brazil. Cardoso NT, Santos BA, Barbosa AV, Superti SV, Teixeira LM, Neves FP. Diagn Microbiol Infect Dis; 2017 Mar 09; 87(3):281-285. PubMed ID: 27939287 [Abstract] [Full Text] [Related]
52. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. Friedland IR, McCracken GH. N Engl J Med; 1994 Aug 11; 331(6):377-82. PubMed ID: 8028618 [Abstract] [Full Text] [Related]
53. [Antimicrobial susceptibility of Streptococcus pneumoniae colonizing the nasopharynx of Colombian children with pneumonia]. Leal AL, Castañeda E. Rev Panam Salud Publica; 1997 Apr 11; 1(4):266-72. PubMed ID: 9303812 [No Abstract] [Full Text] [Related]
54. Resistance of Streptococcus pneumoniae to erythromycin in adults and children. Sempere MA, Gómez J, Ruiz J. J Antimicrob Chemother; 1992 Mar 11; 29(3):348-9. PubMed ID: 1592704 [No Abstract] [Full Text] [Related]
55. Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002). Jones RN, Sader HS, Fritsche TR. Diagn Microbiol Infect Dis; 2004 Jun 11; 49(2):147-9. PubMed ID: 15183865 [Abstract] [Full Text] [Related]
56. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece. Maraki S, Mantadakis E, Samonis G. Chemotherapy; 2010 Jun 11; 56(4):325-32. PubMed ID: 20720416 [Abstract] [Full Text] [Related]
57. Experts release white paper on antimicrobial use and resistance in Iowa. Hill D. Iowa Med; 2001 Jun 11; 91(5):20-1. PubMed ID: 11641997 [No Abstract] [Full Text] [Related]
58. Resistance patterns of streptococcus pneumoniae from carriers attending day-care centers in southwestern Greece. Syrogiannopoulos GA, Grivea IN, Beratis NG, Spiliopoulou AE, Fasola EL, Bajaksouzian S, Appelbaum PC, Jacobs MR. Clin Infect Dis; 1997 Aug 11; 25(2):188-94. PubMed ID: 9332508 [Abstract] [Full Text] [Related]
59. [Various prospective approaches to the treatment of nonspecific lung diseases]. Sil'vestrov VP, Vanina NF. Ter Arkh; 1980 Aug 11; 52(3):3-12. PubMed ID: 6966837 [No Abstract] [Full Text] [Related]
60. [Discussions on PRSP and BLNAR]. Tajima T, Meguro H, Akita H, Iwata T. Jpn J Antibiot; 2001 May 11; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]